The facility, in the northern city of Ravenna, produces
catechol and hydroquinone for the pharmaceutical, agrochemical, flavour and fragrance industries and employs a staff of 40 people.
Borregaard said that there is an overcapacity in the market for catechol a change in this situation is not foreseen in the near future. “The outlook for Borregaard Italia indicates continued losses.”
“We have pursued a number of alternatives for improving the competitiveness of the company, without reaching a sufficient solution. We deeply regret having to make this decision after such strong efforts,” the company said.